PGM3 and glioblastoma: Furthermore, chronic temozolomide exposure activates the HBP-PGM3 axis to elevate O-GlcNAcylation, which inhibits ferroptosis in glioblastoma; this chemoresistance can be reversed by targeting PGM3, thereby reactivating ferroptosis and suppressing tumor growth [21].